-
Should You Own Celgene In 2017? Part 5
Post on 2/2/17
-
Forget Celldex Therapeutics, Inc.: These 2 Stocks Are Better Buys
Post on 2/2/17
-
Pfizer (PFE) Q4 2016 Results - Earnings Call Transcript
Post on 2/1/17
-
Merck Makes Nice With Bristol-Myers Squibb
Post on 2/1/17
-
7 Things You Might Have Missed in Pfizer's Q4 Earnings Slip
Post on 2/1/17
-
Pfizer's 3 Fastest-Growing Drugs
Post on 2/1/17
-
AmerisourceBergen's (ABC) CEO Steven Collis On Q1 2017 Results - Earnings Call Transcript
Post on 2/1/17
-
Johnson & Johnson's Q4 Earnings: What You Need to Know
Post on 2/1/17
-
Instant Analysis: Is Teva Pharmaceutical Industries a Buy on the Dip?
Post on 2/1/17
-
Dayton Children’s Hospital Selects InstaMed, the First and Only P2PE v2.0 Solution for Healthcare
Post on 1/31/17
-
South Jersey Dental Study Club Expands its Continuing Education Programs to the Jersey Shore
Post on 1/31/17
-
Johnson & Johnson Plus Actelion: A Good Combination?
Post on 1/31/17
-
Johnson & Johnson Acquisition Makes It Better
Post on 1/31/17
-
3 Biotech Stocks I'd Buy Right Now
Post on 1/31/17
-
Philmont Guidance Center Joins Holy Redeemer Health System to Expand Behavioral Health Services
Post on 1/30/17
-
Honeywell International's (HON) CEO Dave Cote on Q4 2016 Results - Earnings Call Transcript
Post on 1/30/17
-
Celgene Looks Cheap Right Now
Post on 1/30/17
-
Celgene Corporation Continues Its Double-Digit Growth
Post on 1/30/17
-
How Big Is the Opportunity for Celgene's Otezla Overseas?
Post on 1/30/17
-
Johnson & Johnson (JNJ) Acquires Actelion (ALIOF)
Post on 1/30/17
-
Celgene To Acquire Delinia For Autoimmune Technology
Post on 1/30/17
-
Johnson & Johnson Sets Benchmark With Massive Actelion Price
Post on 1/30/17
-
Johnson & Johnson Too Rich For You? Try This High-Yielding Pharma Stock Instead
Post on 1/30/17
-
3 Most Unbelievably Undervalued Biotech Stocks
Post on 1/30/17
-
Better Buy: Pfizer Inc. vs. Johnson & Johnson
Post on 1/30/17
Philadelphia
